PoTent P2Y12 Inhibitor
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PoTent P2Y12 Inhibitor, covering 2026-02-09 to 2026-02-09. Get the full timeline:
Most recent: Clinical Trial Update: Aspirin and a PoTent P2Y12 Inhibitor Versus Aspirin and Clopidogrel in Patients Undergoing PCI for Complex Lesion [Phase 4]